| Author |
Message |
|
|
|
Wed Nov 05, 2008 2:37 am  |
| Cellcosmet Eye Contour Cream has really good reputation...although I was suggested to be too young to use it, my mom used it and she is pretty satisfied with this product |
|
|
|
|
|
Wed Nov 05, 2008 5:20 am |
wylone, how old are you?
cellcosmet eye contour is supposed to be used from 25+ |
_________________
31, combo - oily, breakout-prone, fair complexion, sensitive and prone to rosacea |
|
sunsun
New Member
 
Joined: 05 Nov 2008
Posts: 6
|
|
|
Wed Nov 05, 2008 6:20 am |
I have net used any of the three. For me ,EA Prevage is good  |
|
|
|
|
|
Thu Nov 06, 2008 1:34 am |
| Sufficient sleep(7-8 hours a day) is the best product to erase your dark cycle among any three-digit-priced eye cream! |
|
|
|
|
|
Fri Dec 02, 2016 4:44 am |
| Cellcosmet Eye Contour Cream +1 |
|
|
|
|
|
Fri Feb 24, 2017 2:58 pm |
| I am loving my lifeline eye cream. Great eyemakeup base too. |
_________________
47, former sunworshipper, skincare addict, oily T-zone, fair skinned, love Vita A, some hyperpigmentation, microneedler. |
|
|
|
|
Mon Feb 27, 2017 7:03 am |
agree on sisleya. i've been using it for couple years. no effect and still see wrinkles growing
| shenpei wrote: |
I keep finding the eye cream for me
My first main concern is dark circles under the eyes so i should try the PTR Vit-K eye cream ,second main concern is wrinkles under the eyes so which one should i try ?
I used the sisleya,but i didn't feel any change  |
|
|
|
|
|
| Fri Apr 19, 2024 7:31 am |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
 |
|
